In a new analysis of the SELECT trial published in JAMA Cardiology, semaglutide 2.4 mg improved clinical outcomes compared ...

The first step in making a big career change is recognizing your “early symptoms,” according to an expert. At the 2026 Women ...

Increased pulse pressure among older women, previously hypothesized to be menopause-related, may be an independent risk for ...

A gastrointestinal robotic endoscopy system has received FDA 510(k) clearance for use in diagnostic and therapeutic ...

Older people who smoke experience greater loneliness than those who do not, according to an abstract presented at the ...

Patients with severe, uncontrolled chronic rhinosinusitis with nasal polyps starting mepolizumab had improved polyp size, ...

Sept. 17 is the first commemoration of National Women in Medicine Day — a movement dedicated to celebrating and recognizing ...

The FDA has granted fast track designation to Yutrepia for the treatment of Raynaud’s phenomenon associated with systemic ...

A street-based treatment program could be an effective and supportive way to provide hepatitis C virus care to adults experiencing unsheltered homelessness, results of a qualitative study ...

LONDON — Real-world, prospective, multicenter study results show high patient satisfaction with Bausch + Lomb’s enVista ...

One presentation focused on 12-month data from the phase 2 ArMaDa study examining OCU410 gene therapy (Ocugen) for geographic atrophy. Two dose levels of OCU410 were compared against a sham control ...

Screening for elevated lipoprotein(a), or Lp(a), and targeting modifiable risk factors and lifestyle, whether done by an ...